BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18078820)

  • 21. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
    Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF
    Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The essential role of FKBP38 in regulating phosphatase of regenerating liver 3 (PRL-3) protein stability.
    Choi MS; Min SH; Jung H; Lee JD; Lee TH; Lee HK; Yoo OJ
    Biochem Biophys Res Commun; 2011 Mar; 406(2):305-9. PubMed ID: 21320469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement of phosphatase of regenerating liver-3 for the nucleolar localization of nucleolin during the progression of colorectal carcinoma.
    Semba S; Mizuuchi E; Yokozaki H
    Cancer Sci; 2010 Oct; 101(10):2254-61. PubMed ID: 20860603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2.
    Min SH; Kim DM; Heo YS; Kim HM; Kim IC; Yoo OJ
    Life Sci; 2010 Jan; 86(1-2):66-72. PubMed ID: 19945467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.
    Pettiford SM; Herbst R
    Oncogene; 2000 Feb; 19(7):858-69. PubMed ID: 10702794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion.
    Sun JP; Wang WQ; Yang H; Liu S; Liang F; Fedorov AA; Almo SC; Zhang ZY
    Biochemistry; 2005 Sep; 44(36):12009-21. PubMed ID: 16142898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling.
    Matter WF; Estridge T; Zhang C; Belagaje R; Stancato L; Dixon J; Johnson B; Bloem L; Pickard T; Donaghue M; Acton S; Jeyaseelan R; Kadambi V; Vlahos CJ
    Biochem Biophys Res Commun; 2001 May; 283(5):1061-8. PubMed ID: 11355880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival.
    Chabot C; Spring K; Gratton JP; Elchebly M; Royal I
    Mol Cell Biol; 2009 Jan; 29(1):241-53. PubMed ID: 18936167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells.
    Achiwa H; Lazo JS
    Cancer Res; 2007 Jan; 67(2):643-50. PubMed ID: 17234774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Properties of an ezrin mutant defective in F-actin binding.
    Saleh HS; Merkel U; Geissler KJ; Sperka T; Sechi A; Breithaupt C; Morrison H
    J Mol Biol; 2009 Jan; 385(4):1015-31. PubMed ID: 19084535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function.
    Rouleau C; Roy A; St Martin T; Dufault MR; Boutin P; Liu D; Zhang M; Puorro-Radzwill K; Rulli L; Reczek D; Bagley R; Byrne A; Weber W; Roberts B; Klinger K; Brondyk W; Nacht M; Madden S; Burrier R; Shankara S; Teicher BA
    Mol Cancer Ther; 2006 Feb; 5(2):219-29. PubMed ID: 16505094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus.
    Aoki N; Matsuda T
    Mol Endocrinol; 2002 Jan; 16(1):58-69. PubMed ID: 11773439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRL-3 activates NF-κB signaling pathway by interacting with RAP1.
    Lian S; Meng L; Liu C; Xing X; Song Q; Dong B; Han Y; Yang Y; Peng L; Qu L; Shou C
    Biochem Biophys Res Commun; 2013 Jan; 430(1):196-201. PubMed ID: 23178297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of silencing phosphatase of regenerationg liver-3 expression by microRNA interference in the growth of gastric cancer.
    Cai SR; Wang Z; Chen CQ; Wu WH; He YL; Zhan WH; Zhang CH; Cui J; Wu H
    Chin Med J (Engl); 2008 Dec; 121(24):2534-8. PubMed ID: 19187591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells.
    Wu X; Zeng H; Zhang X; Zhao Y; Sha H; Ge X; Zhang M; Gao X; Xu Q
    Am J Pathol; 2004 Jun; 164(6):2039-54. PubMed ID: 15161639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The phosphatase of regenerating liver 3 (PRL-3) promotes cell migration through Arf-activity-dependent stimulation of integrin α5 recycling.
    Krndija D; Münzberg C; Maass U; Hafner M; Adler G; Kestler HA; Seufferlein T; Oswald F; von Wichert G
    J Cell Sci; 2012 Aug; 125(Pt 16):3883-92. PubMed ID: 22595524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3.
    Rubio T; Köhn M
    Biochem Soc Trans; 2016 Oct; 44(5):1305-1312. PubMed ID: 27911713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural insights into molecular function of the metastasis-associated phosphatase PRL-3.
    Kozlov G; Cheng J; Ziomek E; Banville D; Gehring K; Ekiel I
    J Biol Chem; 2004 Mar; 279(12):11882-9. PubMed ID: 14704153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation.
    Brown L; Waseem A; Cruz IN; Szary J; Gunic E; Mannan T; Unadkat M; Yang M; Valderrama F; O'Toole EA; Wan H
    Oncogene; 2014 May; 33(18):2363-74. PubMed ID: 23752190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.